Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
16.4 USD | -2.90% | -50.44% | -56.84% |
04/06 | Inhibrx Biosciences Insider Bought Shares Worth $4,927,580, According to a Recent SEC Filing | MT |
31/05 | Inhibrx, Inc.(NasdaqGM:INBX) dropped from S&P Biotechnology Select Industry Index | CI |
1st Jan change | Capi. | |
---|---|---|
-56.84% | 178.74Cr | |
+18.07% | 12TCr | |
+14.32% | 11TCr | |
-3.14% | 2.47TCr | |
+2.71% | 2.27TCr | |
-9.95% | 1.81TCr | |
-41.04% | 1.67TCr | |
-12.59% | 1.66TCr | |
+1.29% | 1.35TCr | |
+23.47% | 1.13TCr |
- Stock Market
- Equities
- INBX Stock
- News Inhibrx, Inc.
- Insider Sell: Inhibrx